Marietta Memorial Hospital Employee Health Benefit Plan v. DaVita, Inc. (2021)
- Docket
- 20-1641
- Decided
- 2021-01-01
- Public Good score
- 42 / 100
- Framers' Intent score
- 45 / 100
Summary
Question: <p>Did the Marietta Memorial Hospital Employee Health Benefit Plan violate the Medicare Secondary Payer Act’s non-discrimination provisions through its reimbursement structure for dialysis providers?</p> Conclusion: <p>The Marietta Plan’s coverage terms for outpatient dialysis do not violate 42 U.S.C. § 1395y(b)(1)(C) because those terms apply uniformly to all covered individuals, and the Medicare Secondary Payer statute does not authorize disparate-impact liability. Justice Brett Kavanaugh authored the 7-2 majority opinion of the Court.</p> <p>Section 1395y(b)(1)(C)(ii) prohibits a plan from differentiating in benefits between individuals with and without end-stage renal disease. The language of the provision cannot fairly be read to authorize liability for disparate-impact claims. Because the Marietta Plan provides the same outpatient dialysis benefits to all Plan participants, whether or not they are eligible for Medicare, it does not violate 42 U.S.C. § 1395y(b)(1)(C).</p> <p>Justice Elena Kagan authored a dissenting opinion, in which Justice Sonia Sotomayor joined, arguing that because outpatient dialysis is an almost perfect proxy for end-stage renal disease, differentiation on the basis of one is equivalent to differentiation on the basis of the other.</p>
Case Brief
Facts
The Marietta Memorial Hospital Employee Health Benefit Plan (the 'Marietta Plan') provided outpatient dialysis coverage with a reimbursement structure that differed for dialysis providers based on whether the patient was eligible for Medicare. DaVita, Inc., a dialysis provider, sued, alleging the Marietta Plan violated the Medicare Secondary Payer Act (MSP) by differentiating benefits between patients with and without end-stage renal disease (ESRD).
Procedural History
DaVita filed suit in federal court, arguing the Plan's reimbursement structure violated 42 U.S.C. § 1395y(b)(1)(C). The district court granted summary judgment for the Marietta Plan, and the Sixth Circuit affirmed. DaVita petitioned for certiorari, which the Supreme Court granted.
Issue
Whether a health benefit plan violates the Medicare Secondary Payer Act’s non-discrimination provisions when it uniformly applies a coverage structure that differentiates based on whether a patient is Medicare-eligible, even if that structure affects ESRD patients disproportionately.
Holding
The Marietta Plan’s reimbursement structure does not violate the Medicare Secondary Payer Act, as it applies uniformly to all covered individuals and the Act does not authorize disparate-impact liability.
Rule
The Medicare Secondary Payer Act’s prohibition on discrimination between patients with and without end-stage renal disease (ESRD) applies only to direct distinctions based on ESRD status, not to neutral policies that incidentally affect ESRD patients. The statute does not create a cause of action for disparate-impact claims.
Reasoning
The Court interpreted the plain language of § 1395y(b)(1)(C), which prohibits plans from 'differen[t] in benefits between individuals who have end-stage renal disease and individuals who do not.' This refers only to intentional discrimination based on ESRD status, not to neutral policies affecting ESRD patients indirectly. The Marietta Plan provided identical dialysis coverage to all participants regardless of ESRD status, making the reimbursement structure non-discriminatory under the statute. The Court rejected DaVita’s disparate-impact argument as unsupported by the statute’s text or legislative history.
Significance
The decision narrowly construes the MSP Act, limiting its application to only intentional discrimination based on ESRD status and explicitly rejecting disparate-impact claims. This provides clarity for health plans in structuring coverage and reinforces that statutory anti-discrimination provisions must be strictly interpreted when not explicitly authorizing disparate-impact liability.
Public Good Analysis
GPT: The ruling prevents disparate-impact claims, allowing health plans to maintain uniform reimbursement structures that effectively disadvantage end-stage renal disease patients requiring dialysis. This undermines access to critical healthcare for a vulnerable group, harming public health equity. | Claude: This decision clarifies the scope of Medicare Secondary Payer Act regulations, impacting healthcare access for those needing dialysis. While seemingly technical, a ruling *against* the plan could have led to increased costs or coverage limitations for all patients due to potential liability concerns, potentially hindering access to vital treatment. The majority opinion prioritizes clear statutory interpretation over expansive claims.
Framers' Intent Analysis
GPT: The case involves a modern statutory interpretation of Medicare law (1965), not constitutional principles. Framers never addressed healthcare benefits or the Medicare Secondary Payer Act, making 'framers intent' entirely inapplicable to this statutory context. | Claude: The Court’s emphasis on textualism and adhering closely to the literal language of the statute aligns with the originalist understanding favored by Framers like Alexander Hamilton who advocated for a system where laws meant exactly what they said. Avoiding the creation of new legal doctrines, such as disparate impact liability when not explicitly authorized by Congress, reinforces the separation of powers and respects the legislative function – something James Madison strongly believed in during debates surrounding the Constitution.